# Taurine Supplementation in Adolescents With Post-COVID Condition

> **NCT07682402** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Alberta** · enrollment: 30 (estimated)

## Conditions studied

- Long COVID
- Post COVID-19 Condition
- PASC Post Acute Sequelae of COVID 19

## Interventions

- **DRUG:** Taurine

## Key facts

- **NCT ID:** NCT07682402
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682402, "Taurine Supplementation in Adolescents With Post-COVID Condition". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*